Jorg C. Hoffmann - Publications

Case Report: Pregnant ROS1+ lung cancer patient treated with crizotinib - Impact on infancy.

Journal: Frontiers in oncology

Published: January 10, 2026

Self-explaining artificial intelligence for the classification of B cell non-Hodgkin lymphoma: A diagnostic decision support study.

Journal: PLoS medicine

Published: December 27, 2025

Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic options.

Journal: Cancer genetics

Published: December 09, 2025

A Thin Film Source in a Solid-State Diffusion Experiment: CoO on SrTiO3.

Journal: Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada

Published: May 12, 2025

Development of an explainable AI system using routine clinical parameters for rapid differentiation of inflammatory conditions.

Journal: Frontiers in immunology

Published: January 03, 2024

Abatacept as salvage therapy for life-threatening refractory autoimmune hemolytic anemia: a case report.

Journal: Hematology (Amsterdam, Netherlands)

Published: May 03, 2023

Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia.

Journal: Current oncology (Toronto, Ont.)

Published: January 16, 2023

The Low Expression of Fc-Gamma Receptor III (CD16) and High Expression of Fc-Gamma Receptor I (CD64) on Neutrophil Granulocytes Mark Severe COVID-19 Pneumonia.

Journal: Diagnostics (Basel, Switzerland)

Published: July 03, 2022

Rituximab induces a flare-up of activated neutrophil extracellular traps under in vitro conditions.

Journal: Immunopharmacology and immunotoxicology

Published: June 13, 2022

Flow cytometry datasets consisting of peripheral blood and bone marrow samples for the evaluation of explainable artificial intelligence methods.

Journal: Data in brief

Published: February 10, 2022

Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia.

Journal: Leukemia

Published: January 05, 2022

Identification of critical hemodilution by artificial intelligence in bone marrow assessed for minimal residual disease analysis in acute myeloid leukemia: The Cinderella method.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Published: December 30, 2021